On Thursday, Santander Consumer USA Holdings Inc (NYSE:SC)’s shares declined -0.32% to $24.76.
Santander Consumer USA Holdings Inc (SC) declared a broad reorganization of its Board of Directors, counting the appointment of four new independent SHUSA directors and the creation of the position of Lead Independent Director.
The new independent SHUSA directors will be Alan Fishman, Chairman of Ladder Capital; Thomas S. Johnson, former Chairman and CEO of GreenPoint Capital; Catherine Keating, CEO of Commonfund; and Richard Spillenkothen, former head of banking supervision at the Federal Reserve Board and former director of Deloitte & Touche LLP.
The new independent SHUSA directors will be Alan Fishman, Chairman of Ladder Capital; Thomas S. Johnson, former Chairman and CEO of GreenPoint Capital; Catherine Keating, CEO of Commonfund; and Richard Spillenkothen, former head of banking supervision at the Federal Reserve Board and former director of Deloitte & Touche LLP.
Santander Consumer USA Holdings Inc., a specialized consumer finance company, provides vehicle finance and unsecured consumer lending products in the United States. The company’s vehicle finance products and services comprise retail installment contracts, vehicle leases, and dealer loans.
Servicesource International Inc (NASDAQ:SREV)’s shares dropped -1.06% to $5.60.
ServiceSource® ( SREV), the global leader in recurring revenue administration, recently declared that it will release its financial results for the second quarter ended June 30, 2015 after market close on Thursday, August 6, 2015. ServiceSource will host a conference call to talk about the results at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that day to review financial results and business outlook.
ServiceSource International, Inc. provides recurring revenue administration, maintenance, support, and subscription for technology and technology-enabled healthcare and life sciences companies. The company operates in two segments: Managed Services, and Cloud and Business Intelligence. It offers end-to-end administration and optimization of the service-contract renewals process, counting data administration, quoting, selling, and recurring revenue business intelligence.
At the end of Thursday’s trade, Amedica Corporation (NASDAQ:AMDA)‘s shares dipped -2.59% to $0.565.
Amedica Corporation (AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, declared that responses to the U.S. Food and Drug Administration (“FDA”) inquiries regarding the Company’s cervical composite silicon nitride interbody device were presented to the FDA on June 30, 2015. Additionally, the Company has received feedback from the FDA regarding its wear testing femoral head protocols.
Submission for 510(k) clearance of the Valeo C Interbody with CsC Osteo-Conductive Scaffolding (“Valeo C CsC”), which was presented in the first quarter of 2015, relates to the Company’s CASCADE clinical trial of its composite silicon nitride spinal interbody devices. Since submission, the Company received a list of questions from the FDA requesting additional information pertaining to the product’s clinical performance data, in addition to indications for use and device description. The Company has responded to the questions and now awaits clearance of the Class II medical device for commercial distribution or additional communication from the FDA.
Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. It offers Valeo silicon nitride interbody spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; and a line of non-silicon nitride spinal fusion products.
WNS (Holdings) Limited (ADR) (NYSE:WNS), ended its Thursday’s trading session with 8.13% gain, and closed at $28.58.
WNS (Holdings) Limited (WNS), a leading provider of global Business Process Administration (BPM) services, recently declared results for the fiscal 2016 first quarter ended June 30, 2015.
Highlights – Fiscal 2016 First Quarter:
GAAP Financials
- Revenue of $134.1 million, up 2.4% from $131.0 million in Q1 of last year and up 1.0% from $132.9 million last quarter.
- Profit of $12.8 million, contrast to $12.1 million in Q1 of last year and $14.7 million last quarter.
- Diluted earnings per ADS of $0.24, contrast to $0.23 in Q1 of last year and $0.28 last quarter.
Non-GAAP Financial Measures*
Revenue less repair payments of $126.5 million, up 3.6% from $122.1 million in Q1 of last year and up 0.3% from $126.1 million last quarter.
Adjusted Net Income (ANI) of $22.6 million, contrast to $20.4 million in Q1 of last year and $22.9 million last quarter.
Adjusted diluted earnings per ADS of $0.42, contrast to $0.39 in Q1 of last year and $0.43 last quarter.
WNS (Holdings) Limited provides business process administration services comprising data, voice, analytical, and business transformation services worldwide. It offers agency, policy and premium administration, investment administration, new business support, UK motor accident administration provision, claims, actuarial, and repair administration services to the insurance industry; sales and customer care, operations support, platform based, and shared services to the travel and leisure industry.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
